Duhn Therapeutics
PrivateLast Round
Strategic
Oct 23, 2024
Company Overview
Duhn Therapeutics is a biotechnology company that develops lipid-based cancer immunotherapies to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Duhn Therapeutics Comparables
Compare Duhn Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BiPER Therapeutics | 76% | |
| Stimunity | 72% | |
| Boehringer Ingelheim | 70% |
Duhn Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Oct 23, 2024 |
Duhn Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Landmark BioVentures AG | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
Monthly visitors grew 190% MoM, reaching 1.3K.
- Mar 5, 2026
Monthly visitors grew 121% MoM, reaching 1.8K.
Duhn Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Duhn Therapeutics's valuation, stock price, and market status.
Is Duhn Therapeutics a public or private company?
Duhn Therapeutics is a private company.
What is the current stock price of Duhn Therapeutics?
Duhn Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Duhn Therapeutics worth (valuation)?
Valuation information for Duhn Therapeutics is not publicly available.
Can I buy Duhn Therapeutics stock?
Duhn Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Duhn Therapeutics's last funding round?
Duhn Therapeutics's most recent funding round was Strategic on October 23, 2024.
Who are the main investors in Duhn Therapeutics?
Key investors in Duhn Therapeutics include Landmark BioVentures AG.
Will Duhn Therapeutics IPO soon?
No public IPO plans have been announced for Duhn Therapeutics.
How can I track Duhn Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Duhn Therapeutics's secondary market activity and sign up for updates.